Moneycontrol
HomeNewsBusinessDelhi CM Arvind Kejriwal urges Centre to direct vaccine makers to increase monthly supply to the region

Delhi CM Arvind Kejriwal urges Centre to direct vaccine makers to increase monthly supply to the region

As per the CM, Delhi has currently vaccinated 2.99 lakh doses in the 18-44 age bracket. Since the third wave is steadily approaching, the goal is to administer vaccines to this group in the next three months, he said.

May 09, 2021 / 20:29 IST
Story continues below Advertisement
Delhi Chief Minister Arvind Kejriwal

Delhi Chief Minister (CM) Arvind Kejriwal has urged vaccine makers Serum Institute and Bharat Biotech to increase their supplies to Delhi, in a letter to Health Minister Dr. Harsh Vardhan.

In it, the CM says when putting both groups i.e., 18-44-year-olds and 45+,  the national capital will require 83 lakh doses per month to vaccinate the population in the next three months.

Story continues below Advertisement

"We have already developed the infrastructure required," he says, adding that currently, they are vaccinating roughly 1 lakh people per day.

CM Kejriwal also said that the government has placed orders with Bharat Biotech and Serum Institute, and has also approached Reddy Labs for Sputnik vaccines.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show